CLINICAL_TRIALS
trial_result
· 2012-09-24
Clinical Trial Update: Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating Epothilone ZK-219477 for recurrent glioblastoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED